5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells

Journal of Neuroscience

Volumn 21, Issue 10, 2001, Pages 3572-3579

  Van De Kar, Louis D ^a   Javed, Adil ^a   Zhang, Yahong ^a   Serres, Florence ^a   Raap, Daní K ^a   Gray, Thackery S ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

ACTH; C fos; Corticosterone; Fos; MDL 100,907; Oxytocin; Prolactin; Renin; Serotonin

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; OXYTOCIN; PROLACTIN; PROTEIN C FOS; RENIN; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; FLUOROBENZENE; NEUROPEPTIDE; PIPERIDINE DERIVATIVE; SEROTONIN 2C RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; CORTICOTROPIN RELEASE; DOSE RESPONSE; DRUG ANTAGONISM; HYPOTHALAMUS; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IMMEDIATE EARLY GENE; MALE; NONHUMAN; ONCOGENE C FOS; OXYTOCIN RELEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; RENIN RELEASE; STRIA TERMINALIS; ANIMAL; ANTERIOR HYPOTHALAMUS; BLOOD; BRAIN; CYTOLOGY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BRAIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROBENZENES; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; NEUROPEPTIDES; OXYTOCIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PIPERIDINES; PROLACTIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RENIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0035872214     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-10-03572.2001     Document Type: Article

References (71)

1. Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat
2. Hemodynamic and renin response to (+)-DOI, a selective 5-HT2 receptor agonist, in conscious rats
3. 1c receptors in rat brain
4. 2A receptor gene polymorphism is associated with food and alcohol intake in obese people
5. 2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses
6. 2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses
7. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats
8. 2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations
9. 2 receptor agonists DOI and a-methyl-5-HT on plasma glucose and insulin levels in the rat
10. Neuroendocrine challenge tests: What can we learn from them?
11. 2 receptor agonist in the rat
12. 2 receptor-induced head-twitch behaviour in mice
13. 2-receptor interactions
14. 2C receptor agonist, RO 600175: A pharmacological analysis
15. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder
16. 2 receptor antagonist
17. Dopamine receptor-mediated regulation of corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus
18. Role of brain serotonergic pathways and hypothalamus in regulation of renin secretion
19. Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus
20. 2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212
21. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems
22. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder
23. Molecular pharmacology and biology of 5-HT1C receptors
24. D-fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala
25. Estrogen, serotonin, and mood disturbance: Where is the therapeutic bridge?
26. Excitation of hypothalamic paraventricular neurons by stimulation of the raphe nuclei
27. 2A antagonist with a favorable CNS safety profile
28. 2A serotonin receptors
29. Chronic electroconvulsive shock decreases (+/-) 1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane hydrochloride (DOI)-induced wet-dog shake behaviors of dexamethasone-treated rats
30. The molecular biology of serotonin receptors: Therapeutic implications for the interface of mood and psychosis
31. 3 receptor agonists, 7-OH-DPAT and quinpirole, on prolactin secretion in rats
32. 2/1C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: Evidence for involvement of dorsal raphe nucleus projection fibres
33. 2A receptor-mediated c-fos expression in rat cerebral cortex
34. Neuroendocrine profile of the potential anxiolytic drug S-20499
35. 2 antagonist
36. 1A agonists
37. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI)
38. 1A agonist 8-OH-DPAT in male rats
39. 1A receptors
40. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study
41. The spectrum of behaviors influenced by serotonin
42. Stimulus-specific expression of inducible transcription factors in identified oxytocin neurones
43. c-Fos proteins, induced by the serotonin receptor agonist DOI, are not expressed in 5-HT2A positive cortical neurons
44. 2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors
45. 5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge
46. The role of serotonin in antipsychotic drug action
47. F]-setoperone PET
48. Cholecystokinin induces c-fos expression in hypothalamic oxytocinergic neurons projecting to the dorsal vagal complex
49. Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat
50. 2 receptors
51. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of renin secretion
52. 1C/2 receptors
53. 2A/2C) receptors
54. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
55. Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: Possible interaction between serotonin and dopamine
56. Paraventricular nucleus magnocellular neuronal responses following electrical stimulation of the midbrain dorsal raphe
57. Clomipramine enhances the cortisol response to 5-HTP: Implications for the therapeutic role of 5-HT2 receptors
58. Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats
59. 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats
60. 1A agonists
61. 2C, receptor
62. 2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: Behavioral, electrophysiological and neurochemical studies
63. 2A/2C receptor activation is differentially regulated in four regions of rat brain
64. Forebrain pathways mediating stress-induced hormone secretion
65. Partial characterization of a renin-releasing factor from plasma and hypothalamus
66. Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion
67. The concept of selectivity in 5-HT receptor research
68. Cholecystokinin activates C-fos expression in hypothalamic oxytocin and corticotropin-releasing hormone neurons
69. 2 receptor subtype mRNAs in rat brain